This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
n11http://dx.doi.org/10.1001/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q72325625
rdf:type
wikibase:Item
schema:description
наукова стаття, опублікована в червні 1995 artículu científicu espublizáu en xunu de 1995 im Juni 1995 veröffentlichter wissenschaftlicher Artikel scientific article published on 01 June 1995 wetenschappelijk artikel article scientifique publié en 1995 գիտական հոդված հրատարակված 1995 թվականի հունիսի 1-ին
p:P577
wds:Q72325625-6F6666F6-66E4-427E-8551-4CF6011C6DD9
wdt:P577
1995-06-01T00:00:00Z
p:P2093
wds:Q72325625-F129866D-D13C-4957-8A70-53CE3EB0E666 wds:Q72325625-5E8C2456-9DD1-432B-B90A-B509489157CB
wdt:P2093
M Karbassi S Nikou
rdfs:label
Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin
skos:prefLabel
Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin
schema:name
Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin
p:P1476
wds:Q72325625-3A424F9C-AE46-45EC-A735-639F37A57024
wdt:P1476
Acute uveitis in patients with acquired immunodeficiency syndrome receiving prophylactic rifabutin
p:P304
wds:Q72325625-6FFF4D2E-C08F-44D4-83FA-142612158C73
wdt:P304
699-701
p:P31
wds:Q72325625-6E30176B-80E2-41D1-935B-A9D5F3855A2E
wdt:P31
wd:Q13442814
p:P921
wds:Q72325625-011191DD-9C9A-41E4-928E-4138AAA4C736 wds:Q72325625-0A517F92-96C0-45A3-AC37-BAC31E928F27
wdt:P921
wd:Q280027 wd:Q1135705
p:P698
wds:Q72325625-21933E0A-7459-4982-B6C6-16ACC38FA586
wdtn:P698
n10:7786200
wdt:P698
7786200
p:P1433
wds:Q72325625-F9A92B5F-FD70-48E4-8FC3-C3E4D1B5F463
wdt:P1433
wd:Q4787301
p:P433
wds:Q72325625-63276706-437B-462D-9869-319D948F0A2A
p:P478
wds:Q72325625-815897FD-14EC-4D2E-86A0-D63392C857DE
wdt:P433
6
wdt:P478
113
p:P356
wds:Q72325625-3AAD4246-D535-4509-B85F-0961E0939E44
wdtn:P356
n11:ARCHOPHT.1995.01100060021011
wdt:P356
10.1001/ARCHOPHT.1995.01100060021011